PeerView Immunology & Transplantation CME/CNE/CPE Audio Podcast
by PVI, PeerView Institute for Medical Education
Is this your podcast?Insights from recent episode analysis
Audience Interest
Podcast Focus
Publishing Consistency
Platform Reach
Insights are generated by CastFox AI using publicly available data, episode content, and proprietary models.
Most discussed topics
Brands & references
Est. Listeners
Insufficient chart data. Estimates will improve as the show charts.
- Per-Episode Audience
Est. listeners per new episode within ~30 days
N/A🎙 Daily cadence·114 episodes·Last published 3w ago - Monthly Reach
Unique listeners across all episodes (30 days)
N/A - Active Followers
Loyal subscribers who consistently listen
N/A
Market Insights
Platform Distribution
Reach across major podcast platforms, updated hourly
Total Followers
—
Total Plays
—
Total Reviews
—
* Data sourced directly from platform APIs and aggregated hourly across all major podcast directories.
On the show
From 12 epsHosts
Not detected.
Recent guests
Recent episodes
Adam Friedman, MD, FAAD - Wheals of Fortune: Chronic Spontaneous Urticaria Challenges and the Road to Resolution
May 29, 2026
55m 16s
Bhavana Pothuri, MD, MS / Premal Thaker, MD, MS - Targeting With Precision in Advanced Ovarian Cancer: Integrating Approved and Novel Agents Into Personalized Treatment Plans
May 29, 2026
51m 15s
Jacinda (JAM) Abdul-Mutakabbir, PharmD, MPH, Richard Dang, PharmD - RSV in Focus: Pharmacists Driving Vaccine Access, Confidence, and Education
May 7, 2026
59m 54s
April W. Armstrong, MD, MPH - A New Era in Psoriasis Care With Oral IL-23 Inhibitors
May 7, 2026
33m 41s
Guy Young, MD - Driving Innovation Forward in Hemophilia B With Gene Therapy: Clinical Conversations on Progress and Guidance on Practical Delivery
Apr 27, 2026
53m 29s
Social Links & Contact
Official channels & resources
Official Website
Login
RSS Feed
Login
| Date | Episode | Topics | Guests | Brands | Places | Keywords | Sponsor | Length | |
|---|---|---|---|---|---|---|---|---|---|
| 5/29/26 | Adam Friedman, MD, FAAD - Wheals of Fortune: Chronic Spontaneous Urticaria Challenges and the Road to Resolution✨ | Chronic Spontaneous UrticariaHealthcare Education+3 | Adam Friedman, MD, FAAD | University of CincinnatiAccreditation Council for Continuing Medical Education (ACCME)+1 | — | Chronic Spontaneous UrticariaCME+3 | Novartis Pharmaceuticals Corporation | 55m 16s | |
| 5/29/26 | Bhavana Pothuri, MD, MS / Premal Thaker, MD, MS - Targeting With Precision in Advanced Ovarian Cancer: Integrating Approved and Novel Agents Into Personalized Treatment Plans✨ | advanced ovarian cancerpersonalized treatment plans+3 | Bhavana Pothuri, MD, MSPremal Thaker, MD, MS | PVI, PeerView Institute for Medical EducationNational Ovarian Cancer Coalition | — | ovarian cancertargeted therapy+3 | GSK | 51m 15s | |
| 5/7/26 | Jacinda (JAM) Abdul-Mutakabbir, PharmD, MPH, Richard Dang, PharmD - RSV in Focus: Pharmacists Driving Vaccine Access, Confidence, and Education✨ | RSVvaccine access+3 | Jacinda (JAM) Abdul-Mutakabbir, PharmD, MPHRichard Dang, PharmD | PeerView Institute for Medical EducationAccreditation Council for Continuing Medical Education (ACCME)+2 | — | RSVvaccine+5 | GSK | 59m 54s | |
| 5/7/26 | April W. Armstrong, MD, MPH - A New Era in Psoriasis Care With Oral IL-23 Inhibitors✨ | psoriasis careoral IL-23 inhibitors+3 | April W. Armstrong, MD, MPH | PeerView Institute for Medical EducationAccreditation Council for Continuing Medical Education+2 | — | psoriasisIL-23 inhibitors+3 | Johnson & Johnson | 33m 41s | |
| 4/27/26 | Guy Young, MD - Driving Innovation Forward in Hemophilia B With Gene Therapy: Clinical Conversations on Progress and Guidance on Practical Delivery✨ | Hemophilia BGene Therapy+3 | Guy Young, MD | PeerView Institute for Medical EducationAccreditation Council for Continuing Medical Education+2 | — | Hemophilia BGene Therapy+3 | CSL Behring | 53m 29s | |
| 4/15/26 | Haydar Frangoul, MD, MS, Akshay Sharma, MBBS, MSc - Transformative Care for Hemoglobinopathies: Guidance on the Gene Therapy Experience in SCD and Thalassemia✨ | hemoglobinopathiesgene therapy+4 | Haydar Frangoul, MD, MSAkshay Sharma, MBBS, MSc | PeerView Institute for Medical EducationAccreditation Council for Continuing Medical Education+2 | — | hemoglobinopathiesgene therapy+5 | Beam Therapeutics | 52m 16s | |
| 4/15/26 | Olalekan Oluwole, MBBS, MPH - ChARTing New Ground in NHL: Practice-Changing Evidence, Real-World Experience, and Outpatient Delivery of Cellular Therapy✨ | cellular therapyNHL+3 | Olalekan Oluwole, MBBS, MPH | PeerView Institute for Medical Education | — | NHLcellular therapy+3 | Bristol Myers Squibb | 1h 00m 56s | |
| 3/24/26 | Philip J. Mease, MD, MACR - Targeting Unmet Needs in Psoriatic Arthritis: Cases in Achieving Treatment Goals With TYK2 Inhibition✨ | Psoriatic ArthritisTYK2 Inhibition+3 | Philip J. Mease, MD, MACR | PVI, PeerView Institute for Medical EducationAccreditation Council for Continuing Medical Education (ACCME)+2 | — | Psoriatic ArthritisTYK2 Inhibition+3 | Bristol Myers Squibb | 51m 14s | |
| 3/4/26 | Seema S. Aceves, MD, PhD - Smoothing the Way in Eosinophilic Esophagitis: Targeted, Team-Based Strategies for Pediatric and Adult Care✨ | Eosinophilic EsophagitisPediatric Care+3 | Seema S. Aceves, MD, PhD | PeerView Institute for Medical EducationAccreditation Council for Continuing Medical Education+2 | — | Eosinophilic Esophagitishealthcare professionals+4 | Regeneron Pharmaceuticals, Inc | 29m 09s | |
| 2/24/26 | Anju T. Peters, MD, MS, Michael Platt, MD, MSc - Treating With Precision in CRSwNP: Defining the Role of Targeted Biologic Therapy for Optimal Patient Outcomes✨ | CRSwNPtargeted biologic therapy+3 | Anju T. Peters, MD, MSMichael Platt, MD, MSc | PeerView Institute for Medical EducationAccreditation Council for Continuing Medical Education+2 | — | CRSwNPbiologic therapy+3 | Regeneron Pharmaceuticals, Inc | 56m 10s | |
Want analysis for the episodes below?Free for Pro Submit a request, we'll have your selected episodes analyzed within an hour. Free, at no cost to you, for Pro users. | |||||||||
| 12/29/25 | Thomas Grader-Beck, MD - Beneath the Surface of Sjögren’s Disease: Understanding Systemic Impact and B-Cell–Mediated Pathways✨ | Sjögren’s DiseaseB-Cell–Mediated Pathways+3 | Thomas Grader-Beck, MD | University of CincinnatiAccreditation Council for Continuing Medical Education (ACCME)+1 | — | Sjögren’s DiseaseB-Cell+5 | Novartis Pharmaceuticals Corporation | 1h 12m 13s | |
| 12/18/25 | Joseph K. Han, MD, FARS, FAAAAI - Tackling CRSwNP Management With Emerging Biologic Therapies Targeting Epithelial Cytokines: Game On!✨ | CRSwNP managementbiologic therapies+3 | Joseph K. Han, MD, FARS, FAAAAI | PeerView Institute for Medical EducationAccreditation Council for Continuing Medical Education+2 | — | CRSwNPbiologic therapies+3 | AstraZeneca Pharmaceuticals | 1h 00m 44s | |
| 12/12/25 | Christine Franzese, MD, FARS, Flavia C.L. Hoyte, MD, FACAAI - The Type 2 Inflammation Connection in CRSwNP: Optimizing Patient Identification and Targeted Treatments | This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/CC/AAPA information, and to apply for credit, please visit us at PeerView.com/MNA865. CME/MOC/CC/AAPA credit will be available until November 18, 2026.The Type 2 Inflammation Connection in CRSwNP: Optimizing Patient Identification and Targeted Treatments In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis program is supported by an independent educational grant from Regeneron Pharmaceuticals, Inc and Sanofi.Disclosure information is available at the beginning of the video presentation. | — | ||||||
| 10/30/25 | Nikhil I. Khushalani, MD - The Immunotherapy Story Continues for CSCC: Insights and Evidence on Advances in Resectable and Unresectable Disease | This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/AAPA information, and to apply for credit, please visit us at PeerView.com/CPY865. CME/AAPA credit will be available until October 20, 2026.The Immunotherapy Story Continues for CSCC: Insights and Evidence on Advances in Resectable and Unresectable Disease In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an independent educational grant from Regeneron Pharmaceuticals, Inc.Disclosure information is available at the beginning of the video presentation. | — | ||||||
| 10/27/25 | Aleena Banerji, MD - Improving the Care of Hereditary Angioedema: Maximizing Protection With Long-Term Prophylaxis | This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA information, and to apply for credit, please visit us at PeerView.com/SPC865. CME/MOC/AAPA credit will be available until October 15, 2026.Improving the Care of Patients With Hereditary Angioedema: Maximizing Protection With Long-Term Prophylaxis In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Ionis Pharmaceuticals, Inc.Disclosure information is available at the beginning of the video presentation. | — | ||||||
| 10/27/25 | Alexis Ogdie, MD, MSCE, Robert H. Eckel, MD, FAHA, FACC - Tackling Obesity in Psoriatic Arthritis: Key to Better Outcomes and Overall Health | This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/CKQ865. CME/AAPA/IPCE credit will be available until October 23, 2026.Tackling Obesity in Psoriatic Arthritis: Key to Better Outcomes and Overall Health In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Lilly.Disclosure information is available at the beginning of the video presentation. | — | ||||||
| 9/26/25 | Kathleen M. Buchheit, MD, Joseph K. Han, MD, FARS, FAAAAI - Navigating Biologic Therapy in CRSwNP: From Patient Selection to Response Assessment | This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/CC/AAPA information, and to apply for credit, please visit us at PeerView.com/FVW865. CME/MOC/CC/AAPA credit will be available until September 28, 2026.Navigating Biologic Therapy in CRSwNP: From Patient Selection to Response Assessment In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis program is supported by an independent educational grant from Regeneron Pharmaceuticals, Inc and Sanofi.Disclosure information is available at the beginning of the video presentation. | — | ||||||
| 9/26/25 | Jennifer Hsiao, MD - Don’t Miss Hidradenitis Suppurativa: Providing Timely Diagnosis and Management Using Novel Agents | This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME information, and to apply for credit, please visit us at PeerView.com/TZU865. CME credit will be available until September 15, 2026.Don’t Miss Hidradenitis Suppurativa: Providing Timely Diagnosis and Management Using Novel AgentsPurdue University College of Pharmacy, an equal access/equal opportunity institution, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.This accredited activity has been developed in collaboration with our educational partner, PVI, PeerView Institute for Medical Education.SupportThis activity is supported by an educational grant from Novartis Pharmaceuticals Corporation.Disclosure information is available at the beginning of the video presentation. | — | ||||||
| 7/11/25 | Jacob Sands, MD - Tailwinds of Innovation in SCLC: Exploring the Therapeutic Potential of ADCs | This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME information, and to apply for credit, please visit us at PeerView.com/XDB865. CME credit will be available until June 26, 2026.Tailwinds of Innovation in SCLC: Exploring the Therapeutic Potential of ADCs In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Daiichi Sankyo, Inc.Disclosure information is available at the beginning of the video presentation. | — | ||||||
| 7/7/25 | Joshua Sabari, MD - Precision Matters in NSCLC: Everything You Need to Know About Biomarker Testing and Targeted Therapies | This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA information, and to apply for credit, please visit us at PeerView.com/ZEV865. CME/MOC/AAPA credit will be available until June 30, 2026.Precision Matters in NSCLC: Everything You Need to Know About Biomarker Testing and Targeted Therapies In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and LUNGevity Foundation, ONC Brothers. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by independent educational grants from AbbVie, AstraZeneca, Johnson & Johnson, Lilly, Nuvalent, Nuvation Bio, and Rigel Pharmaceuticals, Inc.Disclosure information is available at the beginning of the video presentation. | — | ||||||
| 6/30/25 | Tina Cascone, MD, PhD / Heather A. Wakelee, MD, FASCO - Strategies for Immunotherapy Success in NSCLC: How to Incorporate Modern ICI Platforms Across the Disease Continuum | This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA information, and to apply for credit, please visit us at PeerView.com/AWM865. CME/MOC/AAPA credit will be available until June 30, 2026.Strategies for Immunotherapy Success in NSCLC: How to Incorporate Modern ICI Platforms Across the Disease Continuum In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and LUNGevity Foundation. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported through independent educational grants from Bristol Myers Squibb, Merck & Co., Inc., Rahway, NJ, USA, and Regeneron Pharmaceuticals, Inc.Disclosure information is available at the beginning of the video presentation. | — | ||||||
| 6/27/25 | Arndt Vogel, MD, PhD - Refining Treatment Models For Biliary Tract Cancer Aligning Practice With Rapidly Evolving Evidence on Immunotherapy and Targeted Platforms | This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA information, and to apply for credit, please visit us at PeerView.com/VZA865. CME/MOC/AAPA credit will be available until June 29, 2026.Refining Treatment Models For Biliary Tract Cancer Aligning Practice With Rapidly Evolving Evidence on Immunotherapy & Targeted Platforms In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and Cholangiocarcinoma Foundation. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by independent medical education grants from Incyte Corporation, Jazz Pharmaceuticals, Inc., Servier Pharmaceuticals LLC, and Taiho Oncology, Inc.Disclosure information is available at the beginning of the video presentation. | — | ||||||
| 6/17/25 | Michael E. Manning, MD, FAAAAI, FACAAI - From Wheals to Wellness: Transforming Chronic Spontaneous Urticaria Care With Emerging Solutions | This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME information, and to apply for credit, please visit us at PeerView.com/DNY865. CME credit will be available until June 11, 2026.From Wheals to Wellness: Transforming Chronic Spontaneous Urticaria Care With Emerging SolutionsThe University of Cincinnati is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.This activity is developed in collaboration with our educational partner, PVI, PeerView Institute for Medical Education.SupportThis activity is supported by an educational grant from Novartis Pharmaceuticals Corporation.Disclosure information is available at the beginning of the video presentation. | — | ||||||
| 6/11/25 | Anca D. Askanase, MD, MPH / Philip J. Mease, MD, MACR - An Immune Reset for Systemic Lupus Erythematosus: Expanding Therapeutic Horizons With CAR-T Cell Therapy | This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/VEY865. CME/MOC/AAPA/IPCE credit will be available until June 22, 2026.An Immune Reset for Systemic Lupus Erythematosus: Expanding Therapeutic Horizons With CAR-T Cell Therapy In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported through an educational grant from Bristol Myers Squibb.Disclosure information is available at the beginning of the video presentation. | — | ||||||
| 6/11/25 | Hans Lee, MD - Planting Roots for Next-Gen Bispecific Antibodies in Hematologic Cancers: Collaborative Principles to Extend the Reach of Immunotherapy in Myeloma and Lymphoma | This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/PJA865. CME/MOC/NCPD/AAPA/IPCE credit will be available until May 27, 2026.Planting Roots for Next-Gen Bispecific Antibodies in Hematologic Cancers: Collaborative Principles to Extend the Reach of Immunotherapy in Myeloma and Lymphoma In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an independent medical education grant from Regeneron Pharmaceuticals, Inc.Disclosure information is available at the beginning of the video presentation. | — | ||||||
Showing 25 of 119
Pitch Fit is a Pro feature
See how bookable this show is for guests, which brands already advertise, the per-episode ad value, and the best-fit guest and sponsor profile. The numbers are blurred on the free plan.
How readily this show books outside guests like you.
How proven this show is for host-read sponsorships.
For Guests
ProFor Advertisers
ProUpgrade to Pro to unlock guest cadence, sponsor categories, fit scores, and per-episode ad value for this show.